OSI Pharmaceuticals (OSIP) - formerly Oncogene Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DewDiligence_on_SI who wrote (279)	10/11/2005 12:52:39 AM
From: tuck	Read Replies (2) of 447

Rick's been on Goddard's case since before you arrived Dew, so good thing your question is rhetorical. The annoying thing about the merger vote, is that only EYET shareholders have to approve it. OSIP shareholders are stuck with it. Even if the ANCHOR data came out before the shareholder meeting, it wouldn't be likely to stop the munch. I don't remember seeing anything about collar or escape clauses mentioned in the PR, either, so maybe I'll go sniff in EDGAR for a look at the relevant 8-K. Hey, Mr. Daniel Loeb, over here, please! Cheers. Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next